PDCD1 and cervical carcinoma: (ATOMICC) A Randomized, Open Label, Phase II Trial of Anti-PD1, TSR-042, as Maintenance Therapy for Patients with High-risk Locally Advanced Cervical Cancer After Chemo-radiation (34) NCT03833479